- Wang, Chao;
- Fan, Li;
- Khawaja, Rabia R;
- Liu, Bangyan;
- Zhan, Lihong;
- Kodama, Lay;
- Chin, Marcus;
- Li, Yaqiao;
- Le, David;
- Zhou, Yungui;
- Condello, Carlo;
- Grinberg, Lea T;
- Seeley, William W;
- Miller, Bruce L;
- Mok, Sue-Ann;
- Gestwicki, Jason E;
- Cuervo, Ana Maria;
- Luo, Wenjie;
- Gan, Li
Activation of microglia is a prominent pathological feature in tauopathies, including Alzheimer's disease. How microglia activation contributes to tau toxicity remains largely unknown. Here we show that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, activated by tau, drives microglial-mediated tau propagation and toxicity. Constitutive activation of microglial NF-κB exacerbated, while inactivation diminished, tau seeding and spreading in young PS19 mice. Inhibition of NF-κB activation enhanced the retention while reduced the release of internalized pathogenic tau fibrils from primary microglia and rescued microglial autophagy deficits. Inhibition of microglial NF-κB in aged PS19 mice rescued tau-mediated learning and memory deficits, restored overall transcriptomic changes while increasing neuronal tau inclusions. Single cell RNA-seq revealed that tau-associated disease states in microglia were diminished by NF-κB inactivation and further transformed by constitutive NF-κB activation. Our study establishes a role for microglial NF-κB signaling in mediating tau spreading and toxicity in tauopathy.